Caricamento...
Selective Targeting of Multiple Myeloma by B cell Maturation Antigen (BCMA)-specific Central Memory CD8(+) Cytotoxic T Lymphocytes: Immunotherapeutic Application in Vaccination and Adoptive Immunotherapy
To expand the breadth and extent of current multiple myeloma (MM)-specific immunotherapy, we have identified various antigens on CD138+ tumor cells from newly diagnosed MM patients (n=616) and confirmed B-cell Maturation Antigen (BCMA) as a key myeloma-associated antigen. The aim of this study is to...
Salvato in:
| Pubblicato in: | Leukemia |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6728221/ https://ncbi.nlm.nih.gov/pubmed/30872779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-019-0414-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|